Tandem auto-allo-HCT resulted in a reduction in MM progression or relapse by 23% at four years and 33% at eight years but the improvement in PFS failed to reach statistical significance, probably due to the low number of tandem-auto-HCT.
← all excerpts
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
1
—
—